Cyxone AB is a clinical biomedical company with a portfolio of immunomodulatory drugs to treat autoimmune diseases such as multiple sclerosis (MS) and rheumatoid arthritis. The company's drug portfolio is based on two technical pillars in the form of oral molecules and cyclotide-based drugs that inhibit key processes in the body's cells that are typical of various immune disorders.
Cyxone's technologies have the potential t...
Cyxone AB is a clinical biomedical company with a portfolio of immunomodulatory drugs to treat autoimmune diseases such as multiple sclerosis (MS) and rheumatoid arthritis. The company's drug portfolio is based on two technical pillars in the form of oral molecules and cyclotide-based drugs that inhibit key processes in the body's cells that are typical of various immune disorders.
Cyxone's technologies have the potential to address an unmet need by developing new, effective and safe drugs that can improve the quality of life for those affected by autoimmune diseases.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.